We welcome Karla Childers to AI Uncovered. Karla is a long-standing leader in bioethics and data transparency in the pharmaceutical industry. As part of the Office of the Chief Medical Officer at Johnson & Johnson, she brings deep expertise in navigating the ethical implications of emerging technologies, especially artificial intelligence, in medicine and drug development. In this episode, Tim and Karla explore the intersection of AI, bioethics and patient-centered development. They discu...
All content for AI Uncovered is the property of Timothy Martin, Executive VP of Product at Yseop and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
We welcome Karla Childers to AI Uncovered. Karla is a long-standing leader in bioethics and data transparency in the pharmaceutical industry. As part of the Office of the Chief Medical Officer at Johnson & Johnson, she brings deep expertise in navigating the ethical implications of emerging technologies, especially artificial intelligence, in medicine and drug development. In this episode, Tim and Karla explore the intersection of AI, bioethics and patient-centered development. They discu...
Gregor Mittersinker - "AI, ChatGPT, and the Impact on UX & Design"
AI Uncovered
44 minutes
2 years ago
Gregor Mittersinker - "AI, ChatGPT, and the Impact on UX & Design"
We welcome Gregor Mittersinker to AI Uncovered. Gregor is the founder and creative director at Loft. Loft focuses on product development and design with a specialty in building large product ecosystems. In this episode, Tim and Gregor dive deep into UX and design. They discuss how LLMs, like ChatGPT, have impacted UI design, specifically around conversational UI and prompt interfaces. They evaluate how industry specific applications might use a variety of UI techniques to deal with the ...
AI Uncovered
We welcome Karla Childers to AI Uncovered. Karla is a long-standing leader in bioethics and data transparency in the pharmaceutical industry. As part of the Office of the Chief Medical Officer at Johnson & Johnson, she brings deep expertise in navigating the ethical implications of emerging technologies, especially artificial intelligence, in medicine and drug development. In this episode, Tim and Karla explore the intersection of AI, bioethics and patient-centered development. They discu...
